Showing results (461-470 of 495) with videos related to

Sort By:
Pageof 50
Journal of Clinical Medicine|July 12, 2025
Glucose Homeostasis, Metabolomics, and Pregnancy Outcomes After Bariatric Surgery (GLORIA): Protocol for a Multicentre Prospective Cohort StudyEllen Deleus, Niels Bochanen, Dries Ceulemans, et al.
Scientific Reports|November 2, 2024
Boosting the accuracy of existing models by updating and extending: using a multicenter COVID-19 ICU cohort as a proxyDaniek A M Meijs, Laure Wynants, Sander M J van Kuijk, et al.
The Lancet. Oncology|April 12, 2021
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyRobert L Coleman, Domenica Lorusso, Christine Gennigens, et al.
Genome Biology and Evolution|December 23, 2017
A Novel Hantavirus of the European Mole, Bruges Virus, Is Involved in Frequent Nova Virus CoinfectionsLies Laenen, Valentijn Vergote, Liana Eleni Kafetzopoulou, et al.
Emerging Infectious Diseases|December 22, 2020
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease OutcomesTony Wawina-Bokalanga, Bert Vanmechelen, Valentine Lhermitte, et al.
Dermatology and Therapy|July 8, 2025
Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits SignalingBeverly Knight, Brinda Tammara, Nishit B Modi, et al.
Nature Communications|October 28, 2014
Extant diversity of bryophytes emerged from successive post-Mesozoic diversification burstsB Laenen, B Shaw, H Schneider, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 11, 2022
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter centuryJean Claude S Ngabonziza, Leen Rigouts, Gabriela Torrea, et al.
Pageof 50